Trial · NCT03117569
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Undetectable HCV RNA (ITT Population) | Standard Monitoring Schedule | 121 | Participants | ||
| Undetectable HCV RNA (ITT Population) | Simplified Monitoring Schedule | 233 | Participants | ||
| Undetectable HCV RNA (mITT Population) | Standard Monitoring Schedule | 121 | Participants | ||
| Undetectable HCV RNA (mITT Population) | Simplified Monitoring Schedule | 233 | Participants | ||
| Treatment and Study Visits Adherence | Standard Monitoring Schedule | >=95% Adherence | 125 | Participants | |
| Treatment and Study Visits Adherence | Simplified Monitoring Schedule | >=95% Adherence | 241 | Participants | |
| Treatment and Study Visits Adherence | Standard Monitoring Schedule | <95% Adherence | 2 | Participants | |
| Treatment and Study Visits Adherence | Simplified Monitoring Schedule | <95% Adherence | 12 | Participants | |
| Health-related Quality of Life | Standard Monitoring Schedule | Screening | 80 | Full Range 20 to 100 | score on a scale |
| Health-related Quality of Life | Simplified Monitoring Schedule | Screening | 80 | Full Range 40 to 100 | score on a scale |
| Health-related Quality of Life | Standard Monitoring Schedule | Post-treatment week 12 | 85 | Full Range 20 to 100 | score on a scale |
| Health-related Quality of Life | Simplified Monitoring Schedule | Post-treatment week 12 | 89 | Full Range 40 to 100 | score on a scale |
| Number of Virological Failure Participants With NS3 and NS5A Polymorphisms at Baseline and Post-treatment Week 12 | Standard Monitoring Schedule | NS3 Variants at Baseline | 0 | Participants | |
| Number of Virological Failure Participants With NS3 and NS5A Polymorphisms at Baseline and Post-treatment Week 12 | Simplified Monitoring Schedule | NS3 Variants at Baseline | 1 | Participants | |
| Number of Virological Failure Participants With NS3 and NS5A Polymorphisms at Baseline and Post-treatment Week 12 | Standard Monitoring Schedule | NS3 Variants at Failure | 1 | Participants | |
| Number of Virological Failure Participants With NS3 and NS5A Polymorphisms at Baseline and Post-treatment Week 12 | Simplified Monitoring Schedule | NS3 Variants at Failure | 3 | Participants | |
| Number of Virological Failure Participants With NS3 and NS5A Polymorphisms at Baseline and Post-treatment Week 12 | Standard Monitoring Schedule | NS5A Variants at Baseline | 0 | Participants | |
| Number of Virological Failure Participants With NS3 and NS5A Polymorphisms at Baseline and Post-treatment Week 12 | Simplified Monitoring Schedule | NS5A Variants at Baseline | 3 | Participants | |
| Number of Virological Failure Participants With NS3 and NS5A Polymorphisms at Baseline and Post-treatment Week 12 | Standard Monitoring Schedule | NS5A Variants at Failure | 0 | Participants | |
| Number of Virological Failure Participants With NS3 and NS5A Polymorphisms at Baseline and Post-treatment Week 12 | Simplified Monitoring Schedule | NS5A Variants at Failure | 5 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03117569/results